azd1775
Showing 1 - 18 of 18
Uterine Cancer Trial in Boston (AZD1775)
Recruiting
- Uterine Cancer
- AZD1775
-
Boston, MassachusettsDana Farber Cancer Institute
Jul 5, 2022
Advanced Solid Tumours Trial in Denver, Sarasota, Nashville (AZD1775, MEDI4736)
Active, not recruiting
- Advanced Solid Tumours
- AZD1775
- MEDI4736
-
Denver, Colorado
- +2 more
Aug 18, 2022
Advanced Gastric Adenocarcinoma Trial in Seoul (AZD1775, paclitaxel)
Completed
- Advanced Gastric Adenocarcinoma
- AZD1775
- paclitaxel
-
Seoul, Korea, Republic ofSamsung Medical center
Jun 13, 2022
Triple-negative Metastatic Breast Cancer Trial in Boston (Cisplatin, AZD1775)
Completed
- Triple-negative Metastatic Breast Cancer
- Cisplatin
- AZD1775
-
Boston, MassachusettsDana-Farber Cancer Institute
Oct 29, 2021
Carcinoma, Squamous Cell of Head and Neck Trial in Chapel Hill (AZD1775, Cisplatin, Intensity Modulated Radiotherapy Treatments)
Completed
- Carcinoma, Squamous Cell of Head and Neck
- AZD1775
- +2 more
-
Chapel Hill, North CarolinaUNC Lineberger Comprehensive Cancer Center
Jun 27, 2021
Small Cell Lung Cancer Trial in Seoul (AZD1775)
Completed
- Small Cell Lung Cancer
- AZD1775
-
Seoul, Korea, Republic ofSamsung Medical Center
Mar 18, 2021
Hypopharynx Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma, Larynx Cancer Trial in United Kingdom (AZD1775,
Completed
- Hypopharynx Squamous Cell Carcinoma
- +2 more
- AZD1775
- +2 more
-
Birmingham, West Midlands, United Kingdom
- +5 more
Nov 9, 2022
Metastatic Colorectal Cancer Trial in New York (AZD1775, Irinotecan)
Completed
- Metastatic Colorectal Cancer
- AZD1775
- Irinotecan
-
New York, New YorkLaura and Isaac Perlmutter Cancer Center
Oct 8, 2020
Muscle Invasive Bladder Cancer Trial in Worldwide (AZD4547, MEDI4736, Olaparib)
Active, not recruiting
- Muscle Invasive Bladder Cancer
- AZD4547
- +6 more
-
Los Angeles, California
- +26 more
Oct 17, 2022
Children, Adolescents and Young Adults With Refractory or Recurrent Malignancies Trial in Worldwide (Ribociclib, Topotecan,
Unknown status
- Children, Adolescents and Young Adults With Refractory or Recurrent Malignancies
- Ribociclib
- +9 more
-
Copenhagen, Denmark
- +6 more
Feb 23, 2021
Refractory Solid Tumours, Relapsed Small Cell Lung Cancer (SCLC) Trial in Canada, United States (AZD1775, Olaparib)
Completed
- Refractory Solid Tumours
- Relapsed Small Cell Lung Cancer (SCLC)
- AZD1775
- Olaparib
-
Denver, Colorado
- +5 more
Nov 6, 2019
Advanced Solid Tumours Trial in Australia, Japan, Korea, Republic of (AZD1775, Paclitaxel, carboplatin)
Completed
- Advanced Solid Tumours
- AZD1775
- +2 more
-
Liverpool, Australia
- +6 more
Mar 22, 2019
Locally Advanced Solid Tumours, Metastatic Solid Tumours, Ovarian Cancer Trial in Scottsdale, Denver, Nashville (AZD1775)
Completed
- Locally Advanced Solid Tumours
- +2 more
- AZD1775
-
Scottsdale, Arizona
- +2 more
Dec 11, 2018
Small Cell Lung Cancer Trial in Seoul (AZD1775)
Terminated
- Small Cell Lung Cancer
- AZD1775
-
Seoul, Korea, Republic ofKeunchil Park
Sep 18, 2018
Previously Untreated Stage IV Non-Squamous Non Small Cell Lung Cancer Trial in United States (AZD1775, AZD1775 Matching Placebo,
Terminated
- Previously Untreated Stage IV Non-Squamous Non Small Cell Lung Cancer
- AZD1775
- +3 more
-
Englewood, Colorado
- +7 more
Feb 10, 2017
Previously Treated Non Small Cell Lung Cancer Trial in United States (AZD1775, AZD1775 Placebo, Antimitotic Agent)
Terminated
- Previously Treated Non Small Cell Lung Cancer
- AZD1775
- +3 more
-
Birmingham, Alabama
- +11 more
May 6, 2016